title: Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy.
abstract: BACKGROUND
  To develop novel therapeutic approaches for patients with head and neck malignancies, poorly immunogenic murine models of squamous cell carcinoma (SCC) need to be defined.
  
  
  METHODS
  The phenotype, growth characteristics, and responsiveness to tumor-specific T-cell transfer of a spontaneously arising murine SCC (SCC VII) were characterized.
  
  
  RESULTS
  SCC VII expresses major histocompatibility complex (MHC) class I molecules yet is resistant to tumor-specific T-cell killing and relatively insensitive to killing mediated by lymphokine-activated killer (LAK) cells. Intradermal tumors are reproducibly established after vaccination of 5 x 10(4) cells, and systemic micrometastases are apparent after intravenous administration of 2.5 x 10(4) cells. Immunotherapy of 3-day lung metastases using tumor-specific T cells and systemic interleukin-2 (IL-2) was ineffective in reducing the number of metastases in vivo.
  
  
  CONCLUSIONS
  SCC VII is a poorly immunogenic murine squamous cell cancer, which represents an ideal model for preclinical testing of immunotherapeutic approaches for patients with SCC of the upper aerodigestive tract.
authors.affiliation: Department of Otolaryngology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
authors.forename: D
authors.initials: D
authors.lastname: Khurana
authors.forename: E A
authors.initials: EA
authors.lastname: Martin
authors.forename: J L
authors.initials: JL
authors.lastname: Kasperbauer
authors.forename: B W
authors.initials: BW
authors.lastname: O'Malley
authors.forename: D R
authors.initials: DR
authors.lastname: Salomao
authors.forename: L
authors.initials: L
authors.lastname: Chen
authors.forename: S E
authors.initials: SE
authors.lastname: Strome
mesh_terms: D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000628:therapy*; D003602:Cytotoxicity, Immunologic; D004195:Disease Models, Animal; D005260:Female; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000628:therapy*; D016219:Immunotherapy, Adoptive; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D051379:Mice; D008809:Mice, Inbred C3H; D013601:T-Lymphocytes / Q000276:immunology